Skip to main content
. 2000 Jun;44(6):1680–1685. doi: 10.1128/aac.44.6.1680-1685.2000

TABLE 4.

Clinical outcomes for monitored patients

Treatment group No. of patients
Subsequent appearance of:
Complete cure Total
P. vivax
P. falciparum
≤28 days >28 days
CPa 1 21 22
Chloroquine 1 6 14 21
Primaquine 3 2 3 18 26
Quinine 11 2 4 17
Mefloquine 2 15 17
Halofantrine 9 1 2 5 17
Artesunate 12 7 19
Artemether 9 2 6 17
PS  3 + 5 TFsb 2 10
Total 47 + 5 TFs 11 11 92 166
a

CP, chloroquine-primaquine. 

b

TFs, treatment failures.